Search Results1-5 of  5

  • GINNAGA Akihiro ID: 9000005513486

    The Chemo-Sero-Therapeutic Research Institute (2003 from CiNii)

    Articles in CiNii:2

    • Biochemicalengineering application of cyclodextrin derivative for effective production of Pertussis Component Vaccine (1999)
    • Vaccination against Fowlpox Virus Via Drinking Water (2003)
  • GINNAGA Akihiro ID: 9000019092697

    Human Vaccine Production Department, The Chemo-Sero-Therapeutic Research Institute (2012 from CiNii)

    Articles in CiNii:2

    • Type A1 but Not Type A2 Botulinum Toxin Decreases the Grip Strength of the Contralateral Foreleg Through Axonal Transport From the Toxin-Treated Foreleg of Rats (2011)
    • Inhibition of Membrane Na^+ Channels by A Type Botulinum Toxin at Femtomolar Concentrations in Central and Peripheral Neurons (2012)
  • Ginnaga Akihiro ID: 9000361310288

    The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN) (2017 from CiNii)

    Articles in CiNii:1

    • Clinical Study of New Tetravalent (Type A, B, E, and F) Botulinum Toxoid Vaccine Derived from M Toxin in Japan (2017)
  • Ginnaga Akihiro ID: 9000375859087

    The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN) (2017 from CiNii)

    Articles in CiNii:1

    • Venom and Antivenom of the Redback Spider (<i>Latrodectus hasseltii</i>) in Japan. Part II. Experimental Production of Equine Antivenom against the Redback Spider (2017)
  • Ginnaga Akihiro ID: 9000386103421

    The Chemo-Sero-Therapeutic Research Institute (Kaketsuken) (2018 from CiNii)

    Articles in CiNii:1

    • Venom and Antivenom of the Redback Spider (<i>Latrodectus hasseltii</i>) in Japan. Part I. Venom Extraction, Preparation, and Laboratory Testing (2018)
Page Top